Making Modern Treatment Choices in CLL
Wednesday, December 16 at 1:30 PM EST
How does measurable residual disease (MRD) impact treatment decisions and practice patterns for patients with CLL? Learn from experts, including Dr. John Pagel, member of CLL Society’s Board and Medical Advisory Board.
Related posts